CAS 3034215-86-3

1H-Benzimidazole-6-carboxamide, N-[[3-(aminocarbonyl)phenyl]methyl]-2-(6-isoquinolinyl)-1-[(1R,3R)-3-[(methylamino)carbonyl]cyclopentyl]-

Description:

1H-Benzimidazole-6-carboxamide, N-[[3-(aminocarbonyl)phenyl]methyl]-2-(6-isoquinolinyl)-1-[(1R,3R)-3-[(methylamino)carbonyl]cyclopentyl]- is a complex organic compound characterized by its multi-functional structure, which includes a benzimidazole core, carboxamide groups, and various aromatic and aliphatic substituents. This compound is likely to exhibit properties typical of benzimidazole derivatives, such as potential biological activity, including antimicrobial or anticancer effects, due to the presence of the benzimidazole moiety, which is known for its pharmacological significance. The presence of multiple functional groups, including amine and carbonyl functionalities, suggests that it may engage in hydrogen bonding and other intermolecular interactions, influencing its solubility and reactivity. Additionally, the stereochemistry indicated by the (1R,3R) configuration may affect its biological activity and interaction with biological targets. Overall, this compound's unique structure may lead to diverse applications in medicinal chemistry and drug development, although specific biological activities would require empirical investigation.

Formula: C₃₂H₃₀N₆O₃

Synonyms:

• 1H-Benzimidazole-6-carboxamide, N-[[3-(aminocarbonyl)phenyl]methyl]-2-(6-isoquinolinyl)-1-[(1R,3R)-3-[(methylamino)carbonyl]cyclopentyl]-

CDD-1115

CAS: 3034215-86-3

CDD-1115 is a potent and selective BMPR2 inhibitor, with an IC50 of 1.8 nM and a Kiapp of 6.2 nM. It effectively suppresses gene expression mediated by bone morphogenetic proteins (BMPs). BMPs regulate cellular processes in various tissue types, such as the kidneys, skeletal muscle, heart, and reproductive organs, and can induce ectopic bone formation.

Formula: C₃₂H₃₀N₆O₃

Color and Shape: Solid

Molecular weight: 546.619

Ref: TM-T205172